TABLE 2.
Score (reference) | Elements | Clinical outcome | Clinical application and thresholds |
---|---|---|---|
DF[70] | Serum bilirubin and prothrombin time | Survival at 30 days | ≥32 high risk of mortality and candidacy for corticosteroids |
MELD[71] | Serum bilirubin, INR, serum creatinine | Survival at 30 and 90 days | ≥21 high risk of mortality and candidacy for corticosteroids |
ABIC[72] | Serum bilirubin, INR, serum creatinine, age of the patient | Survival at 90 days and 1 year | ≥9 high risk of mortality ≥6.71 intermediate risk |
GAHS[73] | Serum bilirubin, prothrombin time, serum creatinine, patient’s age, WBC count | Survival at 28 and 84 days | ≥9 high risk of mortality and candidacy for corticosteroids |
Lille[19] | Serum bilirubin at days 0 and 7, prothrombin time, serum creatinine, patient’s age, serum albumin | 6-month survival with corticosteroid treatment | ≥0.45 at day 7; nonresponse to corticosteroids |
SALT[60] | > 10 drinks per day at initial hospitalization, multiple prior rehabilitation attempts, prior alcohol-related legal issues, and prior illicit substance abuse | Sustained alcohol use after LT | ≤5 low risk for alcohol relapse after LT |
Abbreviations: ABIC, age, bilirubin, INR, creatinine; DF, discriminant function; GAHS, Glasgow alcohol hepatitis score; INR, international normalized ratio; MELD, Model for End-Stage Liver Disease; SALT, sustained alcohol use after liver transplant; and WBC, white blood cell.